- Prospective observational study of 60 ASA I-II women undergoing elective total abdominal hysterectomy under general anesthesia, analyzed after six exclusions.
- Compared general anesthesia alone (n = 29) with general anesthesia plus adjunctive truncal regional block (n = 31).
- Richards-Campbell Sleep Questionnaire scores were higher with the block (73.0 ± 11.1 vs 47.9 ± 16.9; P < .001), and modified PSQI worsened only in the anesthesia-alone group (9.0 ± 2.4 to 11.7 ± 2.2; P < .001).
- Authors report lower pain scores and higher satisfaction with the block, and 12-hour VAS pain was the strongest predictor of postoperative PSQI (β = 0.56, P < .001).
Chronic pain
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Prospective multicenter trial of 50 enrolled patients with chronic back and/or leg pain after lumbar spine surgery, of whom 32 completed 12-month activity follow-up.
- Baseline mobility was recorded with an accelerometer-equipped external stimulator, and permanent spinal cord stimulation followed if patients achieved at least 50% pain relief on trial.
- Mobility episodes of at least 30 seconds were 34±27 min/24 hours at baseline versus 92±51 min in healthy controls (p=0.009), and rose significantly only by 12 months (p=0.045).
- The increase was significant in leg-predominant pain (35±27 to 54±32 min, p=0.011) but not back-predominant pain, and mobility correlated with reduced disability (p=0.044) and leg pain (p=0.046).
- A cross-sectional study of 208 adults with cancer pain in a hospital-based palliative care setting used Neurometer quantitative sensory testing.
- Patients were grouped by opioid use and compared on current perception and pain thresholds for Aβ, Aδ, and C fibers, with age-adjusted analyses.
- Pain thresholds did not differ between groups, adjusted or unadjusted, and after age adjustment only Aβ current perception threshold differed significantly.
- The authors concluded that routine opioid use was not associated with clinically meaningful threshold changes, while cautioning about the cross-sectional design and residual confounding.
- Retrospective cohort study using VA Corporate Data Warehouse records of 30,462 veterans diagnosed with fibromyalgia, with comparisons of women and men.
- Nine co-occurring chronic overlapping pain conditions and use of nonpharmacological and pharmacological fibromyalgia treatments were compared by sex using logistic regression, unadjusted and adjusted.
- Women had higher adjusted odds of a co-occurring pain condition (aOR 1.17, 95% CI 1.11-1.23) and of multimodal treatment (aOR 1.29, 95% CI 1.19-1.40), but multimodal engagement was 9% to 12% overall.
- Women were also more often prescribed cyclobenzaprine and less often pregabalin, and the authors conclude that receipt of nonpharmacological treatments was low in both sexes.
- Retrospective observational comparative-effectiveness cohort of 90 patients with moderate-to-severe knee osteoarthritis, followed for 24 months.
- Compared cooled genicular radiofrequency ablation alone (n=50) with the same ablation plus intra-articular botulinum toxin type A (n=40), with a planned repeat BoNT-A injection at about 12 months in the combination group.
- Significant treatment-by-time interactions were found for NRS (ß=-0.84, 95% CI -1.21 to -0.47; P=0.0002) and WOMAC (ß=-6.3, 95% CI -9.4 to -3.2; P=0.0003).
- At 24 months, responder rates were 86.5% with combination therapy versus 51.1% with ablation alone (P=0.0004); the authors call for randomized trials to confirm this.
- A single-center retrospective study of 31 patients, with 162 serial blood samples drawn before pump refills during intrathecal bupivacaine for cancer pain.
- Serum bupivacaine concentration was examined against daily dose and infusion flow rate, with body mass index also assessed as a factor.
- Mean serum concentration was 167.7 µg/L (SD 266.2) at a mean daily dose of 39.5 mg/day (SD 31.4), and concentration rose with dose.
- Higher flow rates stayed independently associated with concentration after adjusting for dose, and the authors conclude exposure is well below the toxicity threshold.
- Cross-sectional study of 20 healthy, physically active, full-busted women assigned female at birth, recruited at a university research center in Houston.
- Self-reported neck, back, arm pain and mastalgia were compared with estradiol, progesterone, glycated hemoglobin, anthropometric measures, and mental health indicators.
- Musculoskeletal pain, anxiety, and depression were reported as significant (P < 0.005), and estradiol, progesterone, and glycated hemoglobin were significantly associated with pain, though no effect sizes are given.
- The authors conclude that hormonal and metabolic health influence pain and that covariates such as self-reported anxiety should be considered when examining pain mechanisms.
- This single-center cross-sectional study compared 101 adults with migraine against 101 age- and sex-matched controls using midsagittal FLAIR MRI.
- Corpus callosum genu, truncus, splenium thickness and length were measured by Witelson segmentation, then correlated with clinical measures within the migraine group.
- Migraine patients had thinner genu (10.41 vs 11.43 mm), truncus (5.91 vs 6.68 mm), and splenium (10.73 vs 11.13 mm), all P < 0.05, with no length difference.
- Genu thickness correlated with age at onset (r = 0.33), disability score (r = 0.37), and disease duration (r = -0.30), while attack frequency showed no association; the authors interpret this as cumulative remodeling.
- Single-center retrospective cohort of 382 patients with thoracic subacute herpetic neuralgia, propensity-matched into 72 pairs of burst-SCS and thoracic paravertebral block recipients.
- Burst spinal cord stimulation was compared with thoracic paravertebral block on pain, breakthrough pain, touch-evoked pain, sleep, and medication use over 12 months.
- Burst-SCS showed greater VAS improvement from discharge through 12 months, higher cure rates, and lower postherpetic neuralgia incidence at 3 months, though the abstract gives no effect sizes or CIs.
- Both procedures relieved pain and improved sleep, and the authors conclude burst-SCS had more favorable outcomes, with no difference in oral morphine equivalent dose.
- A retrospective cohort of 80 patients at a single academic pain center compared posterior interpositional (n=33) and lateral transiliac (n=47) SI joint fusion performed from 2020 to 2025.
- Both approaches were performed by interventional pain physicians, and the study compared short-term pain scores, blood loss, complications, and revision surgery between them.
- Both groups improved mean VAS from 6.6 cm to 3.4 cm at one month, but revision for loss of efficacy was 18.2% for posterior versus 0% for lateral (P = 0.003).
- The authors reported low blood loss and complication rates for both approaches and called for prospective, adequately powered studies to define long-term outcomes.
- Retrospective cohort of 149 patients with predominantly unilateral knee OA at a tertiary pain clinic in India, treated July 2023 to August 2025 and followed for 6 months.
- Compared intra-articular PRP (n=92) with nanofat (n=57), using NPRS pain scores and the 6-minute walk test measured via the Accupedo app.
- Nanofat gave greater, sustained pain relief (P < 0.01) and functional gain (P = 0.006) than PRP; ≥50% relief odds were non-significant (adjusted OR 2.05, 95% CI 0.92 to 4.58).
- Authors conclude nanofat gives greater, longer-lasting benefit but call for randomized trials, and link baseline varus deformity ≥5° to lower odds of significant pain relief.
- Retrospective analysis of FDA MAUDE adverse event reports from 2016 to 2025 for SynchroMed and Prometra intrathecal pumps, with 5,423 morphine-only and 1,072 morphine-bupivacaine reports.
- Compares intrathecal morphine monotherapy with a binary morphine-bupivacaine mixture, looking at dosing and device- and medication-related adverse events.
- The binary group received a higher median morphine dose (2.20 vs 1.50 mg/day) yet had less cognitive impairment (0.56% vs 1.48%, P < 0.05); granulomas trended lower (0.65% vs 1.33%, P = 0.068).
- The authors conclude that adding bupivacaine gives a safety profile similar to morphine alone, with less cognitive impairment and a trend toward fewer granulomas.
- A subsequent health economic analysis of previously published data from a 1-arm, multicenter study in the United States, with no control group.
- The exposure was use of an AI-powered digital self-management tool for chronic pain, and costs and QALYs were modeled from baseline to 6 and 12 weeks.
- At 12 weeks, the authors estimated $127 per user in reduced health care costs, $930 per user in increased annual productivity, and 0.0275 QALYs worth $1375.
- The authors conclude the tool shows potential savings of up to $2432 per person in total, or $7380 per year assuming 70% compliance, supporting it as a treatment alternative.
- Cross-sectional baseline analysis of 598 patients with lumbar spinal stenosis from two spine clinics, split into low (226) and high (108) recovery expectation groups.
- Network analysis compared associations among symptom duration and PROMIS-29 + 2 domains between the low and high expectation groups.
- The two networks showed no significant structural differences and stable strength centralities, and chronicity had no significant associations with other factors in either network.
- Pain interference and fatigue were the most influential factors in both groups, while anxiety was more influential in the low-expectation group.
- Multicenter retrospective cohort of 359 adults with vertebrogenic low back pain and Modic I or II changes who underwent BVNA at seven US centers from 2022 to 2025.
- Patients were grouped by radiofrequency lesion strategy: uniform 7-minute, uniform 15-minute, or mixed 7- and 15-minute lesions.
- Unadjusted ≥50% responder rates were 54.0%, 59.3%, and 73.5% (P = .005); after propensity weighting, mixed versus 15-minute OR was 2.01 (95% CI 0.88–4.59; P = .098).
- The authors found no statistically significant outcome differences across lesion strategies after adjustment, noted that male sex was linked to lower response, and called for prospective studies.